CLASSICAL COMPLEMENT ACTIVATION INDUCED BY PREGNANCY - IMPLICATIONS FOR MANAGEMENT OF CONNECTIVE-TISSUE DISEASES

被引:28
作者
HOPKINSON, ND
POWELL, RJ
机构
[1] Department of Immunology, University Hospital, Queen's Medical Centre
关键词
D O I
10.1136/jcp.45.1.66
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims: To determine the effect of pregnancy on C4d concentrations and to assess whether C4d remains a useful disease activity marker in the management of connective tissue diseases during pregnancy. Methods: Plasma C3, C4, and C4d concentrations were measured in 83 women at various stages of normal pregnancy and compared with those in 80 non-pregnant controls. Results: C3 concentrations in the pregnant women were significantly raised (p = 0.0001) and the C4 concentrations were reduced (p = 0.0007), and accompanied by a significant increase in C4d (p = 0.0001). The C4d:C4 ratio was higher in the pregnant women (p = 0.0001). Conclusions: Pregnancy induces activation of the classical complement pathway. C4d concentrations cannot be used to monitor disease activity in patients with connective tissue diseases during pregnancy.
引用
收藏
页码:66 / 67
页数:2
相关论文
共 11 条
[1]  
FAULK WP, 1980, CLIN EXP IMMUNOL, V40, P299
[2]  
FAULK WP, 1977, CLIN EXP IMMUNOL, V27, P365
[3]  
GALLERY ED, 1981, AUST NZ J MED, V11, P243
[4]   C-3 DEGRADATION PRODUCTS (C3D) IN NORMAL-PREGNANCY [J].
JENKINS, JS ;
POWELL, RJ .
JOURNAL OF CLINICAL PATHOLOGY, 1987, 40 (11) :1362-1363
[5]   IMMUNOHISTOLOGICAL AND ELUTION STUDIES OF HUMAN PLACENTA [J].
MCCORMICK, JN ;
FAULK, WP ;
FOX, H ;
FUDENBERG, HH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1971, 133 (01) :1-+
[6]   THE USE OF C3D AS A MEANS OF MONITORING CLINICAL ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND RHEUMATOID-ARTHRITIS [J].
MORROW, WJW ;
WILLIAMS, DJP ;
FEREC, C ;
CASBURNBUDD, R ;
ISENBERG, DA ;
PAICE, E ;
SNAITH, ML ;
YOUINOU, P ;
LEGOFF, P .
ANNALS OF THE RHEUMATIC DISEASES, 1983, 42 (06) :668-671
[7]  
NITSCHE JF, 1981, AM J CLIN PATHOL, V76, P679
[8]   CORRELATION OF THE ACTIVATION OF THE 4TH COMPONENT OF COMPLEMENT (C-4) WITH DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
SENALDI, G ;
MAKINDE, VA ;
VERGANI, D ;
ISENBERG, DA .
ANNALS OF THE RHEUMATIC DISEASES, 1988, 47 (11) :913-917
[9]  
TAYLOR PV, 1990, PREGNANCY AUTOIMMUNI, P20
[10]   CIRCULATING C-3, C-4, AND C-3 SPLIT PRODUCTS (C3C AND C3D) DURING NORMAL-PREGNANCY [J].
TEISNER, B ;
HAU, J ;
TUCKER, M ;
LAHOOD, J ;
GRUDZINSKAS, JG .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1982, 2 (06) :309-311